Our work spans three interconnected domains that shape the success of biotech and medtech programs. Each engagement is tailored, evidence‑driven, and designed to reduce uncertainty while accelerating progress.
I help teams define regulatory pathways, anticipate requirements, and prepare for interactions with FDA and other agencies. This includes early‑stage planning, risk assessment, regulatory positioning, and development of clear, defensible strategies that support long‑term success.
Reimbursement strategy begins long before commercialization. I support teams in aligning clinical evidence with payer expectations, identifying value propositions, and ensuring that development plans support future coverage and access.
Translational science bridges discovery and real‑world impact. It focuses on the evidence, models, and decision frameworks needed to move a technology from early research through preclinical validation, clinical development, regulatory review, and ultimately into patient care. My work helps innovators de‑risk this pathway by aligning scientific strategy with regulatory expectations, clinical realities, and reimbursement requirements.
